Oncology investors
29 investors that name Oncology among their sectors are recorded here, among them 20 venture capital firms, 3 corporate venture arms, 3 venture studios and 2 accelerators. Stated investment stages run from pre-seed to growth. Most are headquartered in the United States (9), Canada (3) and the United Kingdom (2). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| 7G BioVentures life science · biopharmaceutical · biotechnology · ophthalmic |
Direct investor | Venture capital | Not stated | Burlingame, United States |
| 82VS biotech · drug discovery · oncology · ophthalmology |
Direct investor | Venture studio | Series A | |
| Agent Capital, LLC Rare Diseases · Oncology · Neurology · Immunology |
Direct investor | Venture capital | Seed – Growth | Waltham, United States |
| Aglaia Management B.V. oncology · drug development · life sciences |
Direct investor | Venture capital | Seed | Bilthoven, Netherlands |
| Amplitude Venture Capital precision medicine · biotechnology · drug discovery · oncology |
Direct investor | Venture capital | Not stated | Montreal, Canada |
| Atlas Venture biotechnology · life sciences · therapeutics · gene therapy |
Direct investor | Venture capital | Seed – Series A | Cambridge, United States |
| Ayuh Ventures healthcare · neuroscience · medtech · neurology |
Direct investor | Venture capital | Not stated | |
| BaseLaunch biotech · therapeutics · oncology · immunology |
Direct investor | Accelerator | Pre-seed – Series A | Basel, Switzerland |
| Brandon Capital Partners life science · medical devices · oncology · neuroscience |
Direct investor | Venture capital | Seed – Growth | Melbourne, Australia |
| Cancer Focus Fund oncology · cancer therapies · immunotherapies · CAR-T |
Direct investor | Venture capital | Not stated | Houston, United States |
| CANCER FUND oncology · diagnostics · therapeutics |
Direct investor | Venture capital | Seed – Series A | United States |
| Claris Ventures biopharma · oncology · immunology · rare diseases |
Direct investor | Venture capital | Pre-seed – Series A | Turin, Italy |
| Droia Ventures therapeutics · oncology · genetic disease |
Direct investor | Venture capital | Pre-seed – Series B | Mechelen, Belgium |
| FACIT oncology · therapeutics · diagnostics · medical technologies |
Direct investor | Other | Pre-seed – Series C+ | Toronto, Canada |
| Hadean Ventures life sciences · healthcare · oncology · cardiovascular |
Direct investor | Venture capital | Not stated | Oslo, Norway |
| Hikma Ventures digital health · life sciences · Drug Delivery · Digital Therapeutics |
Direct investor | Corporate venture | Series A – Growth | Amman, Jordan |
| Jeito Capital Biopharma · Oncology · Autoimmune · Ophthalmology |
Direct investor | Venture capital | Series A – Growth | Paris, France |
| Johnson & Johnson Innovation – JJDC pharmaceuticals · medtech · oncology · immunology |
Direct investor | Corporate venture | Seed – Growth | |
| Lumira Ventures life sciences · therapeutics · medical devices · oncology |
Direct investor | Venture capital | Not stated | Toronto, Canada |
| MPM BioImpact biotechnology · drug development · oncology · immunology |
Direct investor | Venture capital | Seed – Growth | Boston, United States |
| o2h Ventures biotech · therapeutics · drug discovery · AI |
Direct investor | Venture capital | Seed – Growth | Cambridge, United Kingdom |
| Panakes Partners Life Sciences · Biotech · Medical Devices · Therapeutics |
Direct investor | Venture capital | Seed – Series A | Milan, Italy |
| Recode Ventures healthcare · deep tech · AI/ML · computational biology |
Direct investor | Venture capital | Seed – Series A | San Francisco, United States |
| Sanofi Ventures Rare diseases · Immunology and inflammation · Oncology · Cell and gene therapy |
Direct investor | Corporate venture | Seed – Series C+ | |
| Slingshot Therapeutics oncology · inflammatory diseases · drug discovery · biotech |
Direct investor | Accelerator | Pre-seed – Seed | London, United Kingdom |
| Sunstone Life Science Ventures life science · therapeutics · oncology · specialty pharma |
Direct investor | Venture capital | Seed – Series B | Copenhagen, Denmark |
| TCG Labs Soleil oncology · autoimmune diseases |
Direct investor | Venture studio | Pre-seed – Seed | South San Francisco, United States |
| TVM Capital Life Science therapeutics · medtech · diagnostics · digital health |
Direct investor | Venture capital | Seed – Growth | |
| Two River life sciences · oncology · immunotherapy · synthetic biology |
Direct investor | Venture studio | Not stated | New York, United States |